Short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy for oligometastatic prostate cancer: a propensity score matching study

被引:4
作者
Chen, Huan [1 ]
Qu, Min [2 ]
Lian, Bi-Jun [1 ]
Wang, Hai-Feng [1 ]
Wang, Yan [1 ]
Dong, Zhen-Yang [1 ]
Zhu, Feng [1 ]
Shi, Zhen-Kai [1 ]
Jia, Ze-Peng [1 ]
Sun, Ying-Hao [1 ]
Gao, Xu [1 ]
机构
[1] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai 200043, Peoples R China
[2] Second Mil Med Univ, Dept Minimally Invas Urol Ctr, Shanghai 200043, Peoples R China
关键词
Oligometastatic; Prostate cancer; Robotics; Propensity score matching; METASTATIC COLORECTAL-CANCER; HEPATIC RESECTION; LIVER RESECTION; LEARNING-CURVE; SURVIVAL; RECURRENCE; RADIOTHERAPY;
D O I
10.1097/CM9.0000000000000590
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The role of local treatment in oligometastatic prostate cancer (PCa) is gaining interest with the oligometastases hypothesis proposed and the improvement of various surgical methods and techniques. This study aimed to compare the short-term therapeutic outcomes of robotic-assisted laparoscopic radical prostatectomy (RALP) for oligometastatic prostate cancer (OPC) vs. localized PCa using propensity score matching. Methods Totally 508 consecutive patients underwent RALP as a first-line treatment. The patients were divided into two groups according to oligometastatic state: the OPC group (n = 41) or the localized PCa group (n = 467). Oligometastatic disease was defined as the presence of two or fewer suspicious lesions. The association between the oligometastatic state and therapeutic outcomes of RALP was evaluated, including biochemical recurrence (BCR) and overall survival (OS). A Cox proportional hazards model was used to assess the possible risk factors for BCR. Results Totally 41 pairs of patients were matched. The median operative time, the median blood loss, the overall positive surgical margin rate, the median post-operative hospital stays, and the post-operative urinary continence recovery rate between the two groups showed no statistical significance. The 4-year BCR survival rates of the OPC group and localized PCa group were 56.7% and 60.8%, respectively, without a significant difference (P = 0.804). The 5-year OS rates were 96.3% and 100%, respectively (P = 0.326). Additionally, the results of Cox regression showed that oligometastatic state was not an independent risk factor for BCR (P = 0.682). Conclusions Our findings supported the safety and effectiveness of RALP in OPC. Additionally, oligometastatic state and sites did not have an adverse effect on BCR independently.
引用
收藏
页码:127 / 133
页数:7
相关论文
共 29 条
[1]   Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology [J].
Antoch, G ;
Vogt, FM ;
Freudenberg, LS ;
Nazaradeh, F ;
Goehde, SC ;
Barkhausen, J ;
Dahmen, G ;
Bockisch, A ;
Debatin, JF ;
Ruehm, SG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (24) :3199-3206
[2]   Robotic-assisted Laparoscopic Radical Prostatectomy From a Single Chinese Center: A Learning Curve Analysis [J].
Chang, Yifan ;
Qu, Min ;
Wang, Linhui ;
Yang, Bo ;
Chen, Rui ;
Zhu, Feng ;
Wang, Haifeng ;
Wang, Yan ;
Lu, Xin ;
Ma, Chunfei ;
Shi, Zhenkai ;
Dong, Zhenyang ;
Chen, Huan ;
Xu, Chuanliang ;
Sun, Yinghao ;
Gao, Xu .
UROLOGY, 2016, 93 :104-111
[3]   Might Men Diagnosed with Metastatic Prostate Cancer Benefit from Definitive Treatment of the Primary Tumor? A SEER-Based Study [J].
Culp, Stephen H. ;
Schellhammer, Paul F. ;
Williams, Michael B. .
EUROPEAN UROLOGY, 2014, 65 (06) :1058-1066
[4]   Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer - Analysis of 1001 consecutive cases [J].
Fong, Y ;
Fortner, J ;
Sun, RL ;
Brennan, MF ;
Blumgart, LH .
ANNALS OF SURGERY, 1999, 230 (03) :309-318
[5]   Radical Prostatectomy in Men with Oligometastatic Prostate Cancer: Results of a Single-institution Series with Long-term Follow-up [J].
Gandaglia, Giorgio ;
Fossati, Nicola ;
Stabile, Armando ;
Bandini, Marco ;
Rigatti, Patrizio ;
Montorsi, Francesco ;
Briganti, Alberto .
EUROPEAN UROLOGY, 2017, 72 (02) :289-292
[6]   Cytoreductive Radical Prostatectomy in Patients with Prostate Cancer and Low Volume Skeletal Metastases: Results of a Feasibility and Case-Control Study [J].
Heidenreich, Axel ;
Pfister, David ;
Porres, Daniel .
JOURNAL OF UROLOGY, 2015, 193 (03) :832-838
[7]   EAU Guidelines on Prostate Cancer. Part II: Treatment of Advanced, Relapsing, and Castration-Resistant Prostate Cancer [J].
Heidenreich, Axel ;
Bastian, Patrick J. ;
Bellmunt, Joaquim ;
Bolla, Michel ;
Joniau, Steven ;
van der Kwast, Theodor ;
Mason, Malcolm ;
Matveev, Vsevolod ;
Wiegel, Thomas ;
Zattoni, Filiberto ;
Mottet, Nicolas .
EUROPEAN UROLOGY, 2014, 65 (02) :467-479
[8]   OLIGOMETASTASES [J].
HELLMAN, S ;
WEICHSELBAUM, RR .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :8-10
[9]  
Jamison RL, 1997, ARCH SURG-CHICAGO, V132, P505
[10]   Does robot-assisted radical prostatectomy benefit patients with prostate cancer and bone oligometastases? [J].
Jang, Won Sik ;
Kim, Myung Soo ;
Jeong, Won Sik ;
Chang, Ki Don ;
Cho, Kang Su ;
Ham, Won Sik ;
Rha, Koon Ho ;
Hong, Sung Joon ;
Choi, Young Deuk .
BJU INTERNATIONAL, 2018, 121 (02) :225-231